Delivery Order SPE2DX22D0049-SPE2D826FA2JB
- Not listed
- This delivery order, awarded on November 27, 2025, represents a $12,139.14 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (CAGE 0U9U0), a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical (SPE2DX vehicle), which extends through December...
- This delivery order, awarded December 8, 2025, represents a $73,142.20 firm fixed-price contract to AmerisourceBergen Drug Corp for pharmaceutical and medical supply delivery to support the Defense Logistics Agency's Medical Supply Chain. The contract, which serves as a child order under AmerisourceBergen's larger prime Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside designation. Performance will be executed from the...
- This delivery order, awarded on November 24, 2025, represents a $71,705.29 firm fixed price contract issued to AmerisourceBergen Drug Corp (CAGE 0U9U0) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a non-set-aside award, this order was competitively procured and reflects...
- This delivery order, awarded December 4, 2025, represents a $1.33 million firm fixed-price contract to AmerisourceBergen Drug Corp for pharmaceutical and medical supply deliveries. The contract, which serves as a child order under a larger indefinite delivery contract vehicle, is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 5,...
- This delivery order, awarded on July 28, 2025, to AmerisourceBergen Drug Corp represents a $61,455.73 firm fixed-price contract funded by the Defense Logistics Agency's Medical Supply Chain for pharmaceutical and medical supply delivery. The contract, with an ultimate completion date of July 29, 2025, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026) with DLA Troop Support Medical. The award was made competitively...
- This delivery order, awarded on October 21, 2025, represents a $7,122.40 firm fixed price contract issued to AmerisourceBergen Drug Corp (CAGE 0U9U0) by the Defense Logistics Agency's Medical Supply Chain division. The non-competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order calls for pharmaceutical products and medical supplies to support...
- This delivery order, awarded November 3, 2025, by the Defense Logistics Agency's Medical Supply Chain, represents a $12,231.73 firm fixed-price contract to AmerisourceBergen Drug Corp (CAGE 0U9U0), with completion targeted for November 4, 2025. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a one billion dollar ceiling and extends through December 2026. This prime indefinite delivery...
- This delivery order, awarded on October 20, 2025, represents a $13,413.71 firm fixed-price contract to AmerisourceBergen Drug Corp for pharmaceutical and medical supply provision. The contract, which is a child award under a larger indefinite delivery vehicle, was issued by the Defense Logistics Agency's Medical Supply Chain division and is set to be completed by October 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- This delivery order, awarded on April 21, 2025, represents a $7,066.11 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (CAGE 0U9U0), the nation's major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves...
- This delivery order, awarded October 13, 2025, represents a $33,832.92 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA2JBDelivery Order
This delivery order, awarded on December 8, 2025, represents a $13,817.42 firm fixed-price contract issued to AmerisourceBergen Drug Corp (CAGE 0U9U0) by the Defense Logistics Agency's Medical Supply Chain division. As a child order under a larger indefinite delivery contract, this award leverages AmerisourceBergen's existing $999.99 billion Indefinite Delivery Vehicle (SPE2DX) with DLA Troop Support Medical, which operates through December 2026. The contract was competitively awarded without set-asides and is scheduled for completion by December 9, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The company's contract history demonstrates capability across diverse therapeutic areas, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order represents one of multiple awards anticipated under the DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative, which is structured to engage multiple regional contractors for worldwide pharmaceutical support to organizations including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 12/7/25 |